Recombinant H7 Hemagglutinin Influenza Vaccine Trial

NCT03038776 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
150
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Vaxine Pty Ltd

Collaborators